ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway

Zhang, Wen; Sun, Ruiqian; Zhang, Yongjun; Hu, Rong; Li, Qian; Wu, Weili; Cao, Xinyu; Zhou, Jiajian; Pei, Jianfeng*; Yuan, Ping*北京大学; 南方医科大学; 中山大学; 6
FEBS Open Bio2021-11DOI: 10.1002/2211-5463.13290
2被引7阅读
引用收藏
分享

摘要

There were approximately 1.93 million new cases and 940 000 deaths from colorectal cancer in 2020. The first-line chemotherapeutic drugs for colorectal cancer are mainly based on 5-fluorouracil, although the use of these drugs is limited by the development of drug resistance. Consequently, there is a need for novel chemotherapeutic drugs for the efficient treatment of colorectal cancer patients. In the present study, we screened 160 drugs approved by the Food and Drug Administration and identified that cabazitaxel (CBT), a microtube inhibitor, can suppress colony formation and cell migration of colorectal cancer cells in vitro. CBT also induces G2/M phase arrest and apoptosis of colorectal cancer cells. Most importantly, it inhibits the growth of colorectal cancer cell xenograft tumors in vivo. Transcriptome analysis by RNA-sequencing revealed that Tub family genes are abnormally expressed in CBT-treated colorectal cancer cells. The expression of several p53 downstream genes that are associated with cell cycle arrest, apoptosis, and inhibition of angiogenesis and metastasis is induced by CBT in colorectal cancer cells. Overall, our results suggests that CBT suppresses colorectal cancer by upregulating the p53 pathway, and thus CBT may have potential as an alternative chemotherapeutic drug for colorectal cancer.

学科与关键词

关键词
cabazitaxelcolorectal cancer cellHCT116RNA-sequencingxenograft
相关
加载中…
  • Evacetrapib Elicits Antitumor Effects on Colorectal Cancer by Inhibiting the Wnt/β-Catenin Signaling Pathway and Activating the JNK Signaling Pathway
    Hu, Limei; Dong, Haiyan; He, Lingyuan; Shi, Mengchen; Xiang, Nanlin; Su, Yixi; Wang, Chen; Tian, Yu; Hu, Yijia; Wang, Huihui; Liu, Huanliang; Wen, Chuangyu*; Yang, Xiangling*Biological and Pharmaceutical Bulletin, 2022, 45(9): 1238-1245.被引 1
  • miR-126-5p affects the chemosensitivity of colorectal cancer cells by regulating SPRED1, ERK1/2 pathway and apoptosis
    Xu, Mingshi; Zhang, Gang*; Gu, Xiaofan; Zhao, Fangqin; Yang, Zhongmin; Zhang, XiongwenGenes & Diseases, 2023, 10(3): 675-678.
  • Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway
    Feng, PanFeng; Zhu, LongXun; Jie, Jing; Yang, PengXiang; Sheng, Nan; Chen, XiangFan*; Chen, XiaJournal of Cancer Research and Clinical Oncology, 2023, 149(7): 3587-3598.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
FEBS Open Bio
发表日期
2021-11
卷期
第 11 卷, 第 11 期
页码
3032-3050
DOI
10.1002/2211-5463.13290
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773156, 31970674]

作者

  • Z

    Zhang, Wen (第一作者)

    6 · sun yat sen univ

  • S

    Sun, Ruiqian

查看全部 10 位作者收起作者
  • Z

    Zhang, Yongjun

    southern med univ

  • H

    Hu, Rong

    6 · sun yat sen univ

  • L

    Li, Qian

    6 · sun yat sen univ

  • W

    Wu, Weili

    6 · sun yat sen univ

  • C

    Cao, Xinyu

    china japan friendship hosp

  • Z

    Zhou, Jiajian

    southern med univ

  • P

    Pei, Jianfeng (通讯)

    peking univ

  • Y

    Yuan, Ping (通讯)

    6 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417